Find clinical trials for Prostate Cancer in Atlanta, GA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Prostate Cancer trials near Atlanta, GA, USA:
of this study is to evaluate the safety, tolerability, and antitumour activity of AZD0754 CAR T-cell therapy in participants with metastatic prostate...
Phase 1, Phase 2
Atlanta, Georgia, United States and 8 other locations
This is a phase 1 study to assess the safety and tolerability of ARX517 in adult subjects with Metastatic Castration-Resistant Prostate Cancer...
Phase 1
Atlanta, Georgia, United States and 8 other locations
Evaluate the safety and tolerability of AMG 509 in adult participants and determine the maximum tolerated dose (MTD) or recommended phase 2 dose (RP2...
Phase 1
Atlanta, Georgia, United States and 50 other locations
To evaluate the safety and tolerability of Tarlatamab and will determine the maximum tolerated dose (MTD) or recommended phase 2 dose (RP2D).
Phase 1
Atlanta, Georgia, United States and 20 other locations
ADT using Degarelix (LHRH antagonist) for men with hormone-sensitive prostate cancer and a rising prostate-specific antige...
Phase 1, Phase 2
Atlanta, Georgia, United States and 3 other locations
clinical efficacy in participants with metastatic hormone-sensitive prostate cancer (mHSPC) by progression-free survival.The resear...
Phase 2
Atlanta, Georgia, United States and 29 other locations
injection for biomarker targeted MR molecular imaging (MRMI) of prostate cancer in patients scheduled for radical prostatectomy....
Phase 1, Phase 2
Atlanta, Georgia, United States
plus prednisone in participants with metastatic castration resistant prostate cancer. Prednisolone may be used instead of prednison...
Phase 2, Phase 3
Atlanta, Georgia, United States and 112 other locations
may slow or stop the spread of prostate tumor cells that need testosterone to grow. The use of hormone therapy with radiation ther ...
Phase 3
Atlanta, Georgia, United States and 3 other locations
Eligible patients will be treated with the combination of lenvatinib and pembrolizumab. A cycle equals 21 days and therapy will continue until radiog...
Phase 2
Atlanta, Georgia, United States and 4 other locations
Clinical trials
Research sites
Resources
Legal